August 13, 2021
1 min read

Decision on Covaxin emergency authorisation expected by Sept: MEA

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine….reports Asian Lite News

The Ministry of External Affairs (MEA) on Thursday said a decision on emergency authorisation for the Covaxin Covid-19 vaccine made by Bharat Biotech is expected to be announced by September as the World Health Organisation (WHO) takes 6-8 weeks to grant the emergency use listing.

In a media briefing, MEA spokesperson Arindam Bagchi said, “Covaxin submitted its application on July 9 so we are expecting a response by September as it takes 6-8 weeks for the WHO to grant the EUL.”

External Affairs Minister S Jaishankar had made a similar statement at the CII annual event.

The World Health Organisation has said the agency expects to make a decision next month on an emergency authorisation for the Indian-made COVID-19 vaccine.

Last week, Bharat Biotech’s Covaxin received a Good Manufacturing Practices (GMP) compliance certificate from Hungary. The certificate of GMP is now listed on the EudraGMDP database which is the collection of records of the European Community of manufacturing authorisations and certificates of good manufacturing practice, Bharat Biotech said.

Asked about the actions taken by the government on easing Covid travel restrictions, the MEA Spokesperson said, “There are many countries where Covid restrictions are there. Not just students, other people who would like to travel are facing problems. As I have said earlier, we attach high importance to ensuring ease of these restrictions whether they live abroad for education or employment. We have been actively taking up this matter at various levels including at the ministerial levels with all of the countries. I am happy to see some forward movements with some of the countries. MEA will continue to attach high priority to this issue.” (India News Network)

ALSO READ: No compromise on Covaxin quality, says Bharat Biotech

ALSO READ: Nod for proposal to study mixing of Covid-19 vaccine doses

Previous Story

Mayor, film industry urge Londoners ‘Back to the Big Screen’

Next Story

Right to shelter doesn’t mean govt housing for unlimited period: SC

Latest from -Top News

Deadly Fever Grips Senegal

Currently, there is no vaccine or antiviral treatment approved for human use against RVF. Senegal is facing a growing public health emergency as the death toll from a Rift Valley Fever (RVF)

Protest Crackdown in Abidjan

The protest ban came just a day before the planned march, with the prefect of Abidjan declaring all gatherings illegal to “preserve public order” ahead of the polls. Authorities in Ivory Coast

Seychelles Chooses Herminie

Herminie’s win gives his United Seychelles party full control of government after it reclaimed a parliamentary majority during last month’s general elections. Seychelles’s opposition leader, Patrick Herminie, has emerged victorious in the

Fragile Peace Returns to Gaza

Carrying bags, blankets, and a few salvaged belongings, families walked through the dusty highway under the afternoon sun. Many pushed carts or led donkeys loaded with what was left of their possessions.

Egypt to Host Gaza Peace Talks

Cairo summit aims to end war and open a new chapter for regional stability. The summit will gather leaders and senior officials from more than 20 countries, including the United Kingdom, France,
Go toTop

Don't Miss

Cong leadership upset over Rajasthan drama

As per state minister Pratap Khachriyawas, 92 MLAs are together

Rahul vows to fill 30 lakh vacant govt jobs from Aug 15

Rahul Gandhi said that Prime Minister Modi wants to deflect